Hemisphere Ventures is an active, early-stage investor supporting pre-seed and seed companies. They focus on innovations improving quality of life and reshaping the future of health, science, and technology.

Hadean Ventures is a European life science venture capital fund manager based in the Nordics. We invest across Europe in companies developing innovative new medical solutions within pharma, biotech, medtech, diagnostics and digital health. Hadean Ventures has offices in Oslo and Stockholm.

HealthQuest Capital is a growth equity and tactical opportunities firm focused on investing in commercial-stage healthcare companies.

Pear VC is a seed-stage venture capital firm that partners with founders at the earliest stages. They focus on building category-defining companies and offer extensive founder services including talent acquisition, go-to-market strategy, and fundraising assistance.

YuanBio Venture Capital is a leading healthcare investment firm focusing on early and growth stage investment opportunities in biotech, medical devices, IVD, and healthcare services. Headquartered in Suzhou bioBay, they have a portfolio of over 190 companies, with 19 listed on major exchanges.

YuanBio Venture Capital is a leading healthcare investment firm focusing on early and growth stage investment opportunities in biotech, medical devices, IVD, and healthcare services. Headquartered in Suzhou bioBay, they have a portfolio of over 190 companies, with 19 listed on major exchanges.

Vertex Ventures HC is a healthcare and life sciences venture capital fund investing across medical devices, biotech, diagnostics, and digital health services. They invest in companies at all stages of development, from early-stage to commercial-stage, focusing on areas with significant unmet needs.

Social Starts is a venture capital partnership employing a data-driven approach to investing in early-stage companies. Their focus is on moment-of-inception and Series A rounds, with a current emphasis on health and happiness startups.

Keshif Ventures fosters the growth of the San Diego data science ecosystem through investments in early-stage teams focused on building infrastructure or enterprise solutions. They focus on supporting companies developing innovative technologies across various sectors.

Two Sigma Ventures is an early-stage venture capital firm investing in companies run by highly driven people.

Adjuvant Capital is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges. It focuses on historically overlooked market segments, leveraging expertise to translate opportunities into social and financial returns. The firm's investment model is heavily influenced by global trends such as climate change and antimicrobial resistance.

Decheng Capital is a global life sciences investment firm providing capital and strategic support to early-stage and growth-stage healthcare companies. They focus on companies with revolutionary technologies and strong market presence. Founded in 2012, Decheng has over $2 billion in capital.